About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Mankind Pharma Ltd.
BSE Code 543904
ISIN Demat INE634S01028
Book Value 386.60
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 834016.43
P/E 48.96
EPS 41.27
Face Value 1  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
25-Mar-2026 2008.45 2038.50 1990.00 2020.25 408997 822336003
24-Mar-2026 1942.70 2006.00 1917.75 1987.25 22875 44755703
23-Mar-2026 1998.00 1998.95 1909.90 1922.45 14922 28962943
20-Mar-2026 2001.60 2032.00 1967.90 1999.75 80243 160270937
19-Mar-2026 2099.40 2099.40 1995.00 2001.25 15863 32243952
18-Mar-2026 2060.60 2129.50 2056.20 2102.40 5638 11876138
17-Mar-2026 2092.35 2106.00 2056.00 2067.45 81271 168538766
16-Mar-2026 2100.65 2140.80 2082.05 2091.90 9917 20915434
13-Mar-2026 2190.75 2203.35 2127.75 2137.65 19250 41460635
12-Mar-2026 2234.90 2243.00 2186.00 2208.35 3604 7966626
11-Mar-2026 2232.10 2256.05 2221.55 2243.45 15134 33962721
10-Mar-2026 2208.05 2245.00 2169.35 2237.80 18499 40738081
09-Mar-2026 2125.00 2170.75 2107.35 2162.05 29131 62032800
06-Mar-2026 2248.55 2248.55 2178.45 2186.45 7592 16692479
05-Mar-2026 2214.40 2238.00 2191.25 2225.45 6161 13661553
04-Mar-2026 2203.35 2233.75 2195.00 2204.75 7387 16368093
02-Mar-2026 2060.35 2251.30 2060.35 2244.95 39732 88155396
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.